Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-027714
Filing Date
2025-02-26
Accepted
2025-02-26 16:05:35
Documents
105
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cprx-20241231.htm   iXBRL 10-K 3938814
2 EX-19.1 cprx-ex19_1.htm EX-19.1 76409
3 EX-23.1 cprx-ex23_1.htm EX-23.1 4172
4 EX-31.1 cprx-ex31_1.htm EX-31.1 13741
5 EX-31.2 cprx-ex31_2.htm EX-31.2 13757
6 EX-32.1 cprx-ex32_1.htm EX-32.1 6755
7 EX-32.2 cprx-ex32_2.htm EX-32.2 6769
8 GRAPHIC img136052313_0.jpg GRAPHIC 550827
  Complete submission text file 0000950170-25-027714.txt   15998381

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cprx-20241231.xsd EX-101.SCH 1625009
108 EXTRACTED XBRL INSTANCE DOCUMENT cprx-20241231_htm.xml XML 2856526
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33057 | Film No.: 25669962
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)